RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
RGDX was delisted on the 2nd of July, 2015.
1 hedge funds and large institutions have $0 invested in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in 2015 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 16 closing their positions.
94% less funds holding
Funds holding: 17 → 1 (-16)
100% less capital invested
Capital invested by funds: $4.81M → $0 (-$4.81M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 16
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BM
Bridger Management
New York
|
-$1.96M |
| 2 |
LPU
Lansdowne Partners (UK)
London,
United Kingdom
|
-$1.24M |
| 3 |
1WCM
12 West Capital Management
New York
|
-$798K |
| 4 |
AIC
AWM Investment Company
New York
|
-$484K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$208K |
RGDX Hedge Fund Activity: Q3 2015 in Review
1 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) for Q3 2015, worth a combined $0 — down 100% from $4.81M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of RGDX and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Bridger Management, exiting entirely with an estimated $1.96M sold.
- 1 institutional investor held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) as of Q3 2015, down from 17 in Q2 2015.
- Funds reported $0 of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) stock for Q3 2015, down 100% quarter-over-quarter.
- 0 funds opened new RESPONSE GENETICS, INC COMMON SHS (DELAWARE) positions in Q3 2015 and 16 closed out, a net change of -16 holders.
- The largest RESPONSE GENETICS, INC COMMON SHS (DELAWARE) seller in Q3 2015 was Bridger Management, an estimated $1.96M sold.
Based on aggregated 13F filings for Q3 2015.